The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes - PubMed (original) (raw)

Multicenter Study

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes

Merlin C Thomas et al. Diabetes Care. 2011 Apr.

Abstract

Objective: Many guidelines recommend reduced consumption of salt in patients with type 1 diabetes, but it is unclear whether dietary sodium intake is associated with mortality and end-stage renal disease (ESRD).

Research design and methods: In a nationwide multicenter study (the FinnDiane Study) between 1998 and 2002, 2,807 enrolled adults with type 1 diabetes without ESRD were prospectively followed. Baseline urinary sodium excretion was estimated on a 24-h urine collection. The predictors of all-cause mortality and ESRD were determined by Cox regression and competing risk modeling, respectively.

Results: The median follow-up for survival analyses was 10 years, during which 217 deaths were recorded (7.7%). Urinary sodium excretion was nonlinearly associated with all-cause mortality, such that individuals with the highest daily urinary sodium excretion, as well as the lowest excretion, had reduced survival. This association was independent age, sex, duration of diabetes, the presence and severity of chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR] and log albumin excretion rate), the presence of established cardiovascular disease, and systolic blood pressure. During follow-up, 126 patients developed ESRD (4.5%). Urinary sodium excretion was inversely associated with the cumulative incidence of ESRD, such that individuals with the lowest sodium excretion had the highest cumulative incidence of ESRD.

Conclusions: In patients with type 1 diabetes, sodium was independently associated with all-cause mortality and ESRD. Although we have not demonstrated causality, these findings support the calls for caution before applying salt restriction universally. Clinical trials must be performed in diabetic patients to formally test the utility/risk of sodium restriction in this setting.

PubMed Disclaimer

Figures

Figure 1

Figure 1

The association between 24-h urinary sodium excretion and all-cause mortality modeled within the conventional Cox model as a cubic regression spline presented as

Supplementary Table 2

.

Figure 2

Figure 2

The cumulative incidence of ESRD over the 10th, 25th, 50th, 75th, and 90th percentiles of 24-h urinary sodium excretion, adjusted for other covariate predictors and accounting for pre-ESRD mortality as the competing risk (full Fine-Gray proportional hazards competing risk regression model is presented as

Supplementary Table 3

).

Similar articles

Cited by

References

    1. Bantle JP, Wylie-Rosett J, Albright AL, et al. American Diabetes Association Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl. 1):S61–S7810.2337/dc08-S061 - DOI - PubMed
    1. Graham I, Atar D, Borch-Johnsen K, et al. European Society of Cardiology (ESC) European Association for Cardiovascular Prevention and Rehabilitation (EACPR) Council on Cardiovascular Nursing. European Association for Study of Diabetes (EASD) International Diabetes Federation Europe (IDF-Europe) European Stroke Initiative (EUSI) Society of Behavioural Medicine (ISBM) European Society of Hypertension (ESH) WONCA Europe (European Society of General Practice/Family Medicine) European Heart Network (EHN) European Atherosclerosis Society (EAS) European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14(Suppl. 2):S1–S11310.1097/01.hjr.0000277983.23934.c9 - DOI - PubMed
    1. Grassi G, Dell’Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002;106:1957–196110.1161/01.CIR.0000033519.45615.C7 - DOI - PubMed
    1. Graudal NA, Galløe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998;279:1383–139110.1001/jama.279.17.1383 - DOI - PubMed
    1. Petrie JR, Morris AD, Minamisawa K, et al. Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998;83:1552–155710.1210/jc.83.5.1552 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources